MRG003 May Become New Favorite in Nasopharyngeal Cancer Treatment, 216,000 Patients Could Benefit, Annual Sales May Exceed $1.5 Billion!
On October 4, 2024, the European Food Safety Authority (EFSA) issued an official statement announcing plans to revise the maximum residue limits for dichloropropionic acid (MRL) in cereals.
In accordance with the express provisions of Chapter 6 of Regulation (EC) No 396/2005, Nufarm Crop Products UK Ltd. This application for revision has been formally submitted to the relevant Italian national authorities. Following a thorough and detailed assessment, EFSA has concluded that, based on current agricultural practices, the risk of short-term and long-term ingestion of residues resulting from the use of dipropionic acid is unlikely to have a significant impact on consumer health.
Specifically, the data submitted in the application was found to be sufficient to support a revision of the maximum residue limits (MRLs) for active substances in barley, oats, rye and wheat grains. At the same time, at the effective limit of quantitation (LOQ) of 0.01 mg/kg, there are sufficient forced analytical methods to effectively monitor propionic acid drops residues in the commodity and animal substrates under consideration.
Looking for chemical products? Let suppliers reach out to you!
2026-07-21
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
NHU and Sinopec Advance Liquid Methionine Project
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
EFSA Reaffirms Safety of E948 Oxygen and E949 Hydrogen in All Foods No Health Risks Detected
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
Lilly’s Mounjaro Enters China’s State Insurance System
Recommend Reading
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Flexible trading in China's titanium dioxide market in May
-
Cost-driven: Acrylonitrile prices rise slightly
-
Brief Summary of Pure Benzene Trends in March (March 1, 2026 - March 31, 2026) in China
-
Low Levels Across the Entire Cycle + Widening Negative Deviation—Melamine Short-Term Market Weakens
-
Relaxed Demand, Cyclohexanone Prices in Shandong Slightly Decline in April